Literature DB >> 1379607

Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. V. Hierarchy of suppression by myelin basic protein from different species.

A Miller1, O Lider, A al-Sabbagh, H L Weiner.   

Abstract

We have been investigating the suppression of experimental autoimmune encephalomyelitis (EAE) by oral tolerization to autoantigens. In the present study the tolerizing effect of orally administered myelin basic protein (MBP) from different species was examined in the Lewis rat, Hartley guinea pig, and SJL/J mouse model of EAE. Animals were fed guinea pig, rat, bovine, human or mouse-MBP and then immunized with the homologous species of MBP or myelin: Lewis rats were immunized with rat MBP, Hartley guinea pigs with guinea pig-MBP, and SJL/J mice with mouse myelin. Clinical expression of EAE and delayed-type hypersensitivity (DTH) responses to MBP were assessed. In each species, suppression of disease and DTH responses were most pronounced by tolerization with the homologous species of MBP. In addition, cross-species tolerization was observed in each species and in general was less suppressive than homologous MBP although in some instances MBP from a heterologous species was as effective as tolerization with the homologous species. We also studied guinea pig-MBP induced EAE in the Lewis rat because it is a widely studied model of EAE and found that oral tolerization with guinea pig MBP was as suppressive as rat MBP. Of note is that oral tolerization with mouse MBP suppressed myelin-induced EAE in the SJL mouse in which autoimmunity to proteolipid protein appears to play a primary role, suggesting that antigen-driven bystander suppression following oral tolerization with autoantigens (Miller et al., 1991b) may be an important contributing mechanism for suppression of EAE following oral tolerization with MBP in this model.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1379607     DOI: 10.1016/0165-5728(92)90258-m

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  10 in total

Review 1.  Oral tolerance and gut-oriented immune response to dietary proteins.

Authors:  O Alpan
Journal:  Curr Allergy Asthma Rep       Date:  2001-11       Impact factor: 4.806

Review 2.  Oral tolerance and the treatment of rheumatoid arthritis.

Authors:  H L Weiner; Y Komagata
Journal:  Springer Semin Immunopathol       Date:  1998

Review 3.  The experimental autoimmune encephalomyelitis (EAE) model of MS: utility for understanding disease pathophysiology and treatment.

Authors:  Andrew P Robinson; Christopher T Harp; Avertano Noronha; Stephen D Miller
Journal:  Handb Clin Neurol       Date:  2014

Review 4.  Antigen-specific therapies for the treatment of autoimmune diseases.

Authors:  D A Hafler; H L Weiner
Journal:  Springer Semin Immunopathol       Date:  1995

Review 5.  Oral tolerance.

Authors:  H L Weiner
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-08       Impact factor: 11.205

6.  Bystander immunotherapy as a strategy to control allergen-driven airway inflammation.

Authors:  S Navarro; A Lazzari; A Kanda; S Fleury; D Dombrowicz; N Glaichenhaus; V Julia
Journal:  Mucosal Immunol       Date:  2014-11-26       Impact factor: 7.313

7.  A critical role for eotaxin in experimental oral antigen-induced eosinophilic gastrointestinal allergy.

Authors:  S P Hogan; A Mishra; E B Brandt; P S Foster; M E Rothenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

8.  The Peyer's patch is a critical immunoregulatory site for mucosal tolerance in experimental autoimmune encephalomylelitis (EAE).

Authors:  Fei Song; Richard M Wardrop; Ingrid E Gienapp; Scott S Stuckman; Abbie L Meyer; Todd Shawler; Caroline C Whitacre
Journal:  J Autoimmun       Date:  2007-11-14       Impact factor: 7.094

9.  IgG glycosylation in autoimmune-prone strains of mice.

Authors:  K B Bodman; P R Hutchings; P A Jeddi; P J Delves; G A Rook; N Sumar; I M Roitt; P M Lydyard
Journal:  Clin Exp Immunol       Date:  1994-01       Impact factor: 4.330

10.  Induction of immunologic tolerance to myelin basic protein prevents central nervous system autoimmunity and improves outcome after stroke.

Authors:  J Michael Gee; Angela Kalil; Matthew Thullbery; Kyra J Becker
Journal:  Stroke       Date:  2008-03-06       Impact factor: 7.914

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.